In a study involving 185 patients with gastric carcinoma, Choi et al. [28] reported no significant associations between SOX9 protein expression and clinical or pathological characteristics, including tumor invasion, lymph node metastasis, poor differentiation, or overall survival. This evidence concerns the gene SOX9 and metastatic malignant neoplasm in the lymph nodes.